" class="no-js "lang="en-US"> Fujitsu - Medtech Alert
Thursday, March 20, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Fujitsu | Pharmtech Focus

Fujitsu

About Fujitsu

Fujitsu

Fujitsu is the leading Japanese global information and communication technology (ICT) company, offering a full range of technology products, solutions and services. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu people support customers in more than 100 countries.

Related Story

News

 Fujitsu launches Cloud-based Platform for Healthcare in Japan | MTA

Fujitsu launches Cloud-based Platform for Healthcare in Japan

March 28 2023

Fujitsu today announced the launch of a new cloud-based platform that allows users to securely […]

Diseases

 Fujitsu

Fujitsu, Tohoku University Embark on Strategic Alliance to Realize 'well-being Society'

September 26 2022

Fujitsu Limited and Tohoku University today announced the start of a strategic alliance to accelerate […]

Artificial Intelligence

 Fujitsu and MIT's Center for Brains

Fujitsu and MIT's Center for Brains, Minds, and Machines Develop AI Technology Inspired by the Human Brain Able to Recognize Unseen Data with High Accuracy

December 9 2021

Fujitsu Limited and the Center for Brains, Minds and Machines (CBMM) headquartered at the Massachusetts Institute […]

Artificial Intelligence

 Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment | Pharmtech Focus

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

October 19 2021

Aichi Cancer Center and Fujitsu Limited today announced the development of an AI solution able […]

Artificial Intelligence

 Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease | Pharmtech Focus

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

October 11 2021

Fujitsu Limited today announced that it has started joint clinical research with the University of […]

News

 Fujitsu Launches Solution Which Supports Cloud-based Epic EPRs | Pharmtech Focus

Fujitsu Launches Solution Which Supports Cloud-based Epic EPRs

July 23 2021

Fujitsu has launched a solution which will allow NHS trusts and other healthcare organisations in […]